Poolbeg Pharma Archives

Home Poolbeg Pharma

Latest Posts

News and Trends 29 Jun 2023

AI program finds multiple influenza drug targets

Poolbeg Pharma, a clinical-stage biopharma company focusing on infectious and other prevalent diseases, has announced a breakthrough in its world-first influenza Artificial Intelligence (AI) Programme working with the company CytoReason. …

June 29, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 17 Jan 2023

Poolbeg expands POLB 001 into oncology

Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is a strain agnostic, small molecule immunomodulator being studied to address the unmet medical need for…

January 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 21 Dec 2022

Poolbeg identifies new potential drug candidates for RSV infections

Poolbeg Pharma says it has successfully identified potential new drug candidates from its respiratory syncytial virus (RSV) artificial intelligence (AI) program with OneThree Biotech, Inc. Since initiating the collaboration in…

December 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Poolbeg influenza trial successfully completed

Poolbeg Pharma has received initial results having completed its lipopolysaccharide (LPS) human challenge clinical trial for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed to address the…

December 13, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 16 Nov 2022

Poolbeg-led consortium awarded €2.3m to develop oral vaccine platform

EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive grant funding to progress its Oral Vaccine Platform under the Irish Government’s Disruptive Technologies Innovation…

November 16, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

AI program yields multiple novel RSV drug targets

Poolbeg Pharma says it has made a breakthrough in its Artificial Intelligence (AI) program with partner OneThree Biotech, Inc. through the discovery of novel drug targets for the treatment of…

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 4 Oct 2022

Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments

Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for POLB 001, a small molecule immunomodulator for the treatment of severe influenza and POLB 002,…

October 4, 2022 - 2 minutesmins - By Jim Cornall

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering